We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PST:MILPoste Italiane SpA Analysis

Data as of 2026-03-14 - not real-time

€21.18

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Poste Italiane delivered an earnings beat on its insurance segment, reinforcing its cash‑generating capabilities and supporting its attractive dividend yield. The company trades at a price‑to‑earnings multiple well below the industry average, indicating a clear valuation discount. Strong dividend coverage and a payout ratio comfortably below the threshold suggest that the current yield is sustainable. While revenue growth is modestly negative, operating margins remain solid and return on equity is healthy, underscoring resilient profitability. The stock sits just above a key support level and is aligned with its short‑term moving averages, pointing to a technically stable base.
Technical momentum shows a bullish trend despite a bearish MACD signal, and the relative strength index hints at potential upside from oversold conditions. Low beta and modest volatility temper market‑wide risk, though regulatory oversight in the postal sector adds a layer of uncertainty. The combination of a solid dividend, undervalued pricing, and recent earnings strength supports a positive outlook across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with mixed technical signals
  • Recent earnings beat bolstering confidence
  • Sustainable dividend providing immediate return

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation discount relative to peers
  • Strong cash position offsetting debt concerns
  • Continued dividend yield attractiveness

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable earnings from diversified services
  • Undervalued price offering upside potential
  • Resilient dividend supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-3.40%
Profit Margin15.78%
P/E Ratio12.4
ROE17.40%
ROA0.71%
Debt/Equity717.51
P/B Ratio2.0
Industry P/E29.1

Technical Analysis

TrendBullish
RSI35.4
Support€20.83
Resistance€23.87
MA 20€22.42
MA 50€22.39
MA 200€20.45
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price€22.75
Upside/Downside7.40%
GradeUndervalued
TypeValue
Dividend Yield5.84%

Risk Assessment

Beta0.30
Volatility21.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.